TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.32 EUR | -1.06% |
|
+4.42% | -4.80% |
| 06-25 | US CDC alerts healthcare providers of increase in dengue cases | RE |
| 06-25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 811B | ||||||
| 640B | ||||||
| 353B | - | - | - | - | ||
| 333B | ||||||
| 302B |
